A Double-Blind Randomized Controlled Trial of Oxytocin Nasal Spray and Social Cognition Training for Young People With Early Psychosis

An open clinical trial assessing a novel training program for social cognitive impairment in schizophrenia

(2013) Pamela Marsh et al.   Australasian Psychiatry

Clinical classification in mental health at the cross-roads: which direction next?

(2013) Ian B Hickie et al.   BMC Medicine

Social cognition training as an intervention for improving functional outcome in first-episode psychosis: a feasibility study

(2013) Cali F. Bartholomeusz et al.   Early Intervention in Psychiatry

Social cognitive performance as a marker of positive psychotic symptoms in young people seeking help for mental health problems

(2013) Adam J. Guastella et al.   SCHIZOPHRENIA RESEARCH

Effects of single dose intranasal oxytocin on social cognition in schizophrenia

(2013) Michael C. Davis et al.   SCHIZOPHRENIA RESEARCH

Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia

(2012) Amirhossein Modabbernia et al.   CNS DRUGS

A critical review of the influence of oxytocin nasal spray on social cognition in humans: Evidence and future directions

(2012) Adam J. Graustella et al.   HORMONES AND BEHAVIOR

Targeted primary care-based mental health services for young Australians

(2012) Elizabeth M Scott et al.   MEDICAL JOURNAL OF AUSTRALIA

Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research

(2012) Adam J. Guastella et al.   PSYCHONEUROENDOCRINOLOGY

Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine

(2011) Andreas Meyer-Lindenberg et al.   NATURE REVIEWS NEUROSCIENCE

Emotion recognition and oxytocin in patients with schizophrenia

(2011) B. B. Averbeck et al.   PSYCHOLOGICAL MEDICINE

Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia

(2011) Morris B. Goldman et al.   PSYCHOPHARMACOLOGY

Social Cognition in Schizophrenia, Part 1: Performance Across Phase of Illness

(2011) Michael F. Green et al.   SCHIZOPHRENIA BULLETIN

Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia

(2011) Cort A. Pedersen et al.   SCHIZOPHRENIA RESEARCH

Adjunctive Intranasal Oxytocin Reduces Symptoms in Schizophrenia Patients

(2010) David Feifel et al.   BIOLOGICAL PSYCHIATRY

Rethinking schizophrenia

(2010) Thomas R. Insel   NATURE

Magnetic Resonance Imaging Predictors of Treatment Response in First-Episode Schizophrenia

(2010) P. R. Szeszko et al.   SCHIZOPHRENIA BULLETIN

Peripheral oxytocin is associated with reduced symptom severity in schizophrenia

(2010) Leah H. Rubin et al.   SCHIZOPHRENIA RESEARCH

Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders

(2009) Adam J. Guastella et al.   BIOLOGICAL PSYCHIATRY

Neurobiological Markers of Illness Onset in Psychosis and Schizophrenia: The Search for a Moving Target

(2009) Christos Pantelis et al.   NEUROPSYCHOLOGY REVIEW

Social cognition and interaction training (SCIT) for outpatients with schizophrenia: A preliminary study

(2009) David L. Roberts et al.   PSYCHIATRY RESEARCH

What We Know: Findings That Every Theory of Schizophrenia Should Explain

(2009) A. W. MacDonald et al.   SCHIZOPHRENIA BULLETIN

Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice

(2008) H K Caldwell et al.   MOLECULAR PSYCHIATRY

Sharing secrets: Oxytocin and trust in schizophrenia

(2008) Szabolcs Kéri et al.   Social Neuroscience

Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits

(2007) Morris Goldman et al.   SCHIZOPHRENIA RESEARCH